Skip to main content
. 2018 Jul 5;103(10):1654–1661. doi: 10.3324/haematol.2018.189514

Figure 1.

Figure 1.

CONSORT diagram. APL: acute promyelocytic leukemia; CEP-701: lestaurtinib; CBF: core-binding factor; MTOR: mammalian target of rapamycin;